Sign in
CompletedNo phase

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

Key facts

Who runs it
University Hospital, Geneva
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
320 people enrolled
Started
10 Jan 2023
Ended
31 Dec 2024
Type of study
Observational
Record updated
14 January 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • In general good health, as determined by study investigators
  • All participants must be living in the canton of Geneva or working/studying in the canton of Geneva and living in neighboring communities that are within one hour travelling distance by car

Who cannot take part

  • Treated with inhaled drugs by nasal route within the last month
  • Inability to provide written consent
  • Severely immunocompromised subjects as determined by the study investigator

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to learn about the influence of pre-existing mucosal immunity, i.e. antibodies and immune cells that are present at the nasal mucosa before infection, on the infectious viral load after infection with SARS-CoV-2, influenza virus and RSV. The investigators will include app. 320 participants which will be followed for up to 17 months. During this time, the investigators will monitor their nasal mucosal antibodies at regular intervals and compare them to their infectious viral load if they are infected with SARS-CoV-2, influenza virus or RSV. Participants are invited to take a test for SARS-CoV-2, influenza virus or RSV in case of respiratory symptoms. If participants are positive the investigators will follow their viral load kinetics by taking nasopharyngeal swabs every 2-3 days. The investigators will also record the duration and strength of the following symptoms:

Read full original descriptionShow less

* Cough * Fever * Tired * Sore throat * Difficulty breathing * Respiratory distress * Headache * Loss (or alteration) of smell * Loss (or alteration) of sense of taste * Myalgias * Chills * Subjective fever * Pink sputum (or coughing up blood) * Thoracic pain * Runny nose * Abdominal pain * Nausea * Vomiting * Diarrhea * Constipation * Irritated or watery eyes * Rashes * Other

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
14 January 2025